Antiviral and Antimicrobial Technology Market Size, Report by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Antiviral and Antimicrobial Technology Market

5.1. COVID-19 Landscape: Antiviral and Antimicrobial Technology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Antiviral and Antimicrobial Technology Market, By Technology/Mechanism

8.1. Antiviral and Antimicrobial Technology Market, by Technology/Mechanism

8.1.1. Metallic ion/oxide-based (Ag, Cu, ZnO)

8.1.1.1. Market Revenue and Forecast

8.1.2. Organic biocides (QACs, PHMB, isothiazolinones)

8.1.2.1. Market Revenue and Forecast

8.1.3. Photocatalytic (TiOâ‚‚, doped oxides)

8.1.3.1. Market Revenue and Forecast

8.1.4. UV-C germicidal modules (254 nm and UV-C LED)

8.1.4.1. Market Revenue and Forecast

8.1.5. Antiviral/antimicrobial peptides and enzymes

8.1.5.1. Market Revenue and Forecast

8.1.6. Superhydrophobic/microtextured anti-adhesion surfaces

8.1.6.1. Market Revenue and Forecast

8.1.7. Graphene/nanocarbon-based actives

8.1.7.1. Market Revenue and Forecast

Chapter 9. Global Antiviral and Antimicrobial Technology Market, By Form Factor/Delivery

9.1. Antiviral and Antimicrobial Technology Market, by Form Factor/Delivery

9.1.1. Coatings and paints (solvent/waterborne, powder)

9.1.1.1. Market Revenue and Forecast

9.1.2. Additives and masterbatches for polymers

9.1.2.1. Market Revenue and Forecast

9.1.3. Laminates, protective films, and wraps

9.1.3.1. Market Revenue and Forecast

9.1.4. Embedded filters and membranes (air/water)

9.1.4.1. Market Revenue and Forecast

9.1.5. Sprays, wipes, curing/impregnation treatments

9.1.5.1. Market Revenue and Forecast

9.1.6. Device modules (UV-C, plasma, photocatalytic units)

9.1.6.1. Market Revenue and Forecast

Chapter 10. Global Antiviral and Antimicrobial Technology Market, By Substrate/Base Material

10.1. Antiviral and Antimicrobial Technology Market, by Substrate/Base Material

10.1.1. Plastics and polymers (PP, PE, PVC, PU, epoxy)

10.1.1.1. Market Revenue and Forecast

10.1.2. Textiles and nonwovens

10.1.2.1. Market Revenue and Forecast

10.1.3. Paints and architectural coatings

10.1.3.1. Market Revenue and Forecast

10.1.4. Glass and ceramics

10.1.4.1. Market Revenue and Forecast

10.1.5. Metals and copper alloys

10.1.5.1. Market Revenue and Forecast

10.1.6. Paper and paperboard

10.1.6.1. Market Revenue and Forecast

Chapter 11. Global Antiviral and Antimicrobial Technology Market, By End-Use Industry

11.1. Antiviral and Antimicrobial Technology Market, by End-Use Industry

11.1.1. Healthcare and life sciences (hospitals, clinics, labs)

11.1.1.1. Market Revenue and Forecast

11.1.2. Building and construction (commercial, institutional)

11.1.2.1. Market Revenue and Forecast

11.1.3. Consumer goods and apparel

11.1.3.1. Market Revenue and Forecast

11.1.4. Transportation (aviation, rail, automotive, marine)

11.1.4.1. Market Revenue and Forecast

11.1.5. Food and beverage processing and packaging

11.1.5.1. Market Revenue and Forecast

11.1.6. Electronics and appliances

11.1.6.1. Market Revenue and Forecast

11.1.7. Water and wastewater treatment

11.1.7.1. Market Revenue and Forecast

Chapter 12. Global Antiviral and Antimicrobial Technology Market, By Distribution/Go-to-Market

12.1. Antiviral and Antimicrobial Technology Market, by Distribution/Go-to-Market

12.1.1. Direct B2B/OEM integration

12.1.1.1. Market Revenue and Forecast

12.1.2. Industrial distributors and channel partners

12.1.2.1. Market Revenue and Forecast

12.1.3. Private-label/ingredient-brand licensing

12.1.3.1. Market Revenue and Forecast

12.1.4. Online B2B marketplaces and e-procurement

12.1.4.1. Market Revenue and Forecast

Chapter 13. Global Antiviral and Antimicrobial Technology Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Technology/Mechanism

13.1.2. Market Revenue and Forecast, by Form Factor/Delivery

13.1.3. Market Revenue and Forecast, by Substrate/Base Material

13.1.4. Market Revenue and Forecast, by End-Use Industry

13.1.5. Market Revenue and Forecast, by Distribution/Go-to-Market

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Technology/Mechanism

13.1.6.2. Market Revenue and Forecast, by Form Factor/Delivery

13.1.6.3. Market Revenue and Forecast, by Substrate/Base Material

13.1.6.4. Market Revenue and Forecast, by End-Use Industry

13.1.6.5. Market Revenue and Forecast, by Distribution/Go-to-Market

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Technology/Mechanism

13.1.7.2. Market Revenue and Forecast, by Form Factor/Delivery

13.1.7.3. Market Revenue and Forecast, by Substrate/Base Material

13.1.7.4. Market Revenue and Forecast, by End-Use Industry

13.1.7.5. Market Revenue and Forecast, by Distribution/Go-to-Market

13.2. Europe

13.2.1. Market Revenue and Forecast, by Technology/Mechanism

13.2.2. Market Revenue and Forecast, by Form Factor/Delivery

13.2.3. Market Revenue and Forecast, by Substrate/Base Material

13.2.4. Market Revenue and Forecast, by End-Use Industry

13.2.5. Market Revenue and Forecast, by Distribution/Go-to-Market

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Technology/Mechanism

13.2.6.2. Market Revenue and Forecast, by Form Factor/Delivery

13.2.6.3. Market Revenue and Forecast, by Substrate/Base Material

13.2.7. Market Revenue and Forecast, by End-Use Industry

13.2.8. Market Revenue and Forecast, by Distribution/Go-to-Market

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Technology/Mechanism

13.2.9.2. Market Revenue and Forecast, by Form Factor/Delivery

13.2.9.3. Market Revenue and Forecast, by Substrate/Base Material

13.2.10. Market Revenue and Forecast, by End-Use Industry

13.2.11. Market Revenue and Forecast, by Distribution/Go-to-Market

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Technology/Mechanism

13.2.12.2. Market Revenue and Forecast, by Form Factor/Delivery

13.2.12.3. Market Revenue and Forecast, by Substrate/Base Material

13.2.12.4. Market Revenue and Forecast, by End-Use Industry

13.2.13. Market Revenue and Forecast, by Distribution/Go-to-Market

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Technology/Mechanism

13.2.14.2. Market Revenue and Forecast, by Form Factor/Delivery

13.2.14.3. Market Revenue and Forecast, by Substrate/Base Material

13.2.14.4. Market Revenue and Forecast, by End-Use Industry

13.2.15. Market Revenue and Forecast, by Distribution/Go-to-Market

13.3. APAC

13.3.1. Market Revenue and Forecast, by Technology/Mechanism

13.3.2. Market Revenue and Forecast, by Form Factor/Delivery

13.3.3. Market Revenue and Forecast, by Substrate/Base Material

13.3.4. Market Revenue and Forecast, by End-Use Industry

13.3.5. Market Revenue and Forecast, by Distribution/Go-to-Market

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Technology/Mechanism

13.3.6.2. Market Revenue and Forecast, by Form Factor/Delivery

13.3.6.3. Market Revenue and Forecast, by Substrate/Base Material

13.3.6.4. Market Revenue and Forecast, by End-Use Industry

13.3.7. Market Revenue and Forecast, by Distribution/Go-to-Market

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Technology/Mechanism

13.3.8.2. Market Revenue and Forecast, by Form Factor/Delivery

13.3.8.3. Market Revenue and Forecast, by Substrate/Base Material

13.3.8.4. Market Revenue and Forecast, by End-Use Industry

13.3.9. Market Revenue and Forecast, by Distribution/Go-to-Market

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Technology/Mechanism

13.3.10.2. Market Revenue and Forecast, by Form Factor/Delivery

13.3.10.3. Market Revenue and Forecast, by Substrate/Base Material

13.3.10.4. Market Revenue and Forecast, by End-Use Industry

13.3.10.5. Market Revenue and Forecast, by Distribution/Go-to-Market

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Technology/Mechanism

13.3.11.2. Market Revenue and Forecast, by Form Factor/Delivery

13.3.11.3. Market Revenue and Forecast, by Substrate/Base Material

13.3.11.4. Market Revenue and Forecast, by End-Use Industry

13.3.11.5. Market Revenue and Forecast, by Distribution/Go-to-Market

13.4. MEA

13.4.1. Market Revenue and Forecast, by Technology/Mechanism

13.4.2. Market Revenue and Forecast, by Form Factor/Delivery

13.4.3. Market Revenue and Forecast, by Substrate/Base Material

13.4.4. Market Revenue and Forecast, by End-Use Industry

13.4.5. Market Revenue and Forecast, by Distribution/Go-to-Market

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Technology/Mechanism

13.4.6.2. Market Revenue and Forecast, by Form Factor/Delivery

13.4.6.3. Market Revenue and Forecast, by Substrate/Base Material

13.4.6.4. Market Revenue and Forecast, by End-Use Industry

13.4.7. Market Revenue and Forecast, by Distribution/Go-to-Market

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Technology/Mechanism

13.4.8.2. Market Revenue and Forecast, by Form Factor/Delivery

13.4.8.3. Market Revenue and Forecast, by Substrate/Base Material

13.4.8.4. Market Revenue and Forecast, by End-Use Industry

13.4.9. Market Revenue and Forecast, by Distribution/Go-to-Market

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Technology/Mechanism

13.4.10.2. Market Revenue and Forecast, by Form Factor/Delivery

13.4.10.3. Market Revenue and Forecast, by Substrate/Base Material

13.4.10.4. Market Revenue and Forecast, by End-Use Industry

13.4.10.5. Market Revenue and Forecast, by Distribution/Go-to-Market

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Technology/Mechanism

13.4.11.2. Market Revenue and Forecast, by Form Factor/Delivery

13.4.11.3. Market Revenue and Forecast, by Substrate/Base Material

13.4.11.4. Market Revenue and Forecast, by End-Use Industry

13.4.11.5. Market Revenue and Forecast, by Distribution/Go-to-Market

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Technology/Mechanism

13.5.2. Market Revenue and Forecast, by Form Factor/Delivery

13.5.3. Market Revenue and Forecast, by Substrate/Base Material

13.5.4. Market Revenue and Forecast, by End-Use Industry

13.5.5. Market Revenue and Forecast, by Distribution/Go-to-Market

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Technology/Mechanism

13.5.6.2. Market Revenue and Forecast, by Form Factor/Delivery

13.5.6.3. Market Revenue and Forecast, by Substrate/Base Material

13.5.6.4. Market Revenue and Forecast, by End-Use Industry

13.5.7. Market Revenue and Forecast, by Distribution/Go-to-Market

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Technology/Mechanism

13.5.8.2. Market Revenue and Forecast, by Form Factor/Delivery

13.5.8.3. Market Revenue and Forecast, by Substrate/Base Material

13.5.8.4. Market Revenue and Forecast, by End-Use Industry

13.5.8.5. Market Revenue and Forecast, by Distribution/Go-to-Market

Chapter 14. Company Profiles

14.1. Microban International

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Sanitized AG

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. BioCote Ltd

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Sciessent LLC

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Polygiene Group (incl. Addmaster/BIOMASTER)

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Arxada (formerly Lonza Specialty Ingredients)

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. BASF SE

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Dow Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. AkzoNobel N.V.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. PPG Industries, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The major players in the antiviral and antimicrobial technology market include Microban International, Sanitized AG, BioCote Ltd, Sciessent LLC, Polygiene Group (incl. Addmaster/BIOMASTER), Arxada (formerly Lonza Specialty Ingredients), BASF SE, Dow Inc., AkzoNobel N.V., PPG Industries, Inc., The Sherwin-Williams Company, Nippon Paint Holdings Co., Ltd., Cupron Inc., Wieland (CuVerro copper alloys), and Signify (UV-C disinfection systems).

The driving factors of the antiviral and antimicrobial technology market are the awareness of infectious disease threats, with increased focus on healthcare-associated infections and a global demand for protective impurity solutions.

North America region will lead the global antiviral and antimicrobial technology market during the forecast period 2025 to 2034.